Chemist + Druggist is part of Pharma Intelligence UK Limited

This is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.


This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By

UsernamePublicRestriction

English free script plan halted

Plans by the former Labour government to extend free prescriptions to all patients with long-term conditions in England have been scrapped as part of the latest Department of Health (DH) spending review.The move follows the announcement that prescription fees will be abolished in Scotland next year (C+D, October 23, p7). Experts said although the decision to keep the charges in England would have no financial impact on pharmacies, it could raise patient concerns about the system.

Alastair Buxton, head of NHS services at PSNC, said: “I think with patients in Wales and soon, Scotland, enjoying free prescriptions, it could raise a kind of ‘West Lothian question’.” He added that the only change  that free prescriptions would bring would be the removal of a layer of bureaucracy for pharmacists.His views were echoed by community pharmacist Michael Maguire, who also called for a review of the whole English system. Mr Maguire, of Marton Pharmacy in Middlesbrough, said: “It does seem strange that in Wales and Scotland people will be able to get prescriptions for free, whereas in England there are some long-term conditions that are covered and some that aren’t.”A spokesperson from the DH said the exact terms of the original plans to remove the charges in England had never been set out and added that the “status quo” for prescriptions would not change for patients and pharmacists.

Topics

         
Pharmacist Manager
Barnsley
£30 per hour

Apply Now
Latest News & Analysis
See All
UsernamePublicRestriction

Register

CD013349

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel